Another suggested mechanism is VPA induced telogen effluvium, which may be linked to its aromatase-inhibiting effects, potentially leading to male pattern baldness through subsequent hyperandrogenism (Praharaj et al., 2022). The gene discussed is CYP19A1; the disease is androgenetic alopecia.